English
Back
Download
Log in to access Online Inquiry
Back to the Top
Bitcoin back to $100k? Breakthrough imminent?
Views 19.4M Contents 2132

Why Tempest Therapeutics, Inc. (TPST) is a good buy

Why Tempest Therapeutics Inc. ( $Tempest Therapeutics (TPST.US)$  ) is a good buy:
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.

2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies for treating hepatocellular carcinoma, which is moving towards a Phase 3 trial.

3. Strong Performance: TPST has shown impressive returns, with a year-to-date return of 79.42% and a one-year return of 76.54%, outperforming the S&P 500.

4. Analyst Ratings: 3 Analysts have given TPST a strong buy rating and 3 Analysts have given TPST a buy rating, with a price target of $5 minimum, $18.75 average, and $47 max. This is significantly higher than its current trading price.

These factors suggest that TPST has strong potential for growth, especially if their clinical trials continue to show positive results.
Why Tempest Therapeutics, Inc. (TPST) is a good buy
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
2
3
+0
1
Translate
Report
23K Views
Comment
Sign in to post a comment
BUY & HODL $CGBS, $LMT, $F, $ADP, $BR, S&P 500, DOW JONES, NASDAQ
176
Followers
15
Following
416
Visitors
Follow